Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Total Liabilities of $138.6 million for Q1 2026, up 39.59% year-over-year from $99.3 million in Q1 2025, and down 15.88% quarter-over-quarter from $164.8 million in Q4 2025.
Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Total Liabilities history runs 12 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 39.59% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (up 39.59% YoY), while the FY2025 annual figure was $164.8 million, up 46.41% from the prior year.
- Total Liabilities for Q1 2026 stood at $138.6 million, down from $164.8 million in the prior quarter.
- The five-year high for Total Liabilities was $202.0 million in Q2 2022, with the low at $99.3 million in Q1 2025.
- The 5-year median for Total Liabilities is $179.7 million (2024), against an average of $163.3 million.
- Peak annual rise in Total Liabilities reached 46.41% in 2025, while the deepest fall reached 44.96% in 2025.
- Organogenesis Holdings' Total Liabilities stood at $183.7 million in 2022, then declined by 1.27% to $181.4 million in 2023, then slumped by 37.93% to $112.6 million in 2024, then surged by 46.41% to $164.8 million in 2025, then dropped by 15.88% to $138.6 million in 2026.
- Business Quant data shows ORGO's Total Liabilities at $138.6 million in Q1 2026, $164.8 million in Q4 2025, and $123.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 118.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.31 Mn |
| Mar 31, 2026 | 138.65 Mn |
| Dec 31, 2025 | 164.81 Mn |
| Sep 30, 2025 | 123.85 Mn |
| Jun 30, 2025 | 99.91 Mn |
| Mar 31, 2025 | 99.33 Mn |
| Dec 31, 2024 | 112.57 Mn |
| Sep 30, 2024 | 167.75 Mn |
| Jun 30, 2024 | 179.66 Mn |
| Mar 31, 2024 | 180.45 Mn |
| Dec 31, 2023 | 181.36 Mn |
| Sep 30, 2023 | 185.78 Mn |
| Jun 30, 2023 | 179.03 Mn |
| Mar 31, 2023 | 182.41 Mn |
| Dec 31, 2022 | 183.69 Mn |
| Sep 30, 2022 | 200.94 Mn |
| Jun 30, 2022 | 201.97 Mn |
| Mar 31, 2022 | 194.74 Mn |
| Dec 31, 2021 | 201.92 Mn |
| Sep 30, 2021 | 181.25 Mn |